Cargando…
Using economic evaluations in implementation science to increase transparency in costs and outcomes for organizational decision-makers
BACKGROUND: Economic evaluations frequently are utilized to compare the value of different interventions in medicine and health in concrete terms. Implementation science also would benefit from the incorporation of economic evaluations, but such studies are rare in the literature. The National Cance...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004101/ https://www.ncbi.nlm.nih.gov/pubmed/35410434 http://dx.doi.org/10.1186/s43058-022-00295-1 |
_version_ | 1784686218144907264 |
---|---|
author | Saldana, Lisa Ritzwoller, Debra P. Campbell, Mark Block, Eryn Piper |
author_facet | Saldana, Lisa Ritzwoller, Debra P. Campbell, Mark Block, Eryn Piper |
author_sort | Saldana, Lisa |
collection | PubMed |
description | BACKGROUND: Economic evaluations frequently are utilized to compare the value of different interventions in medicine and health in concrete terms. Implementation science also would benefit from the incorporation of economic evaluations, but such studies are rare in the literature. The National Cancer Institute has supported a special collection of articles focusing on economic evaluations in implementation science. Even when interventions are supported by substantial evidence, they are implemented infrequently in the field. Implementation costs are important determinants for whether organizational decision-makers choose to adopt an intervention and whether the implementation process is successful. Economic evaluations, such as cost-effectiveness analyses, can help organizational decision-makers choose between implementation approaches for evidence-based interventions by accounting for costs and succinctly presenting cost/benefit tradeoffs. MAIN TEXT: This manuscript presents a discussion of important considerations for incorporating economic evaluations into implementation science. First, the distinction between intervention and implementation costs is presented, along with an explanation of why the comprehensive representation of implementation costs is elusive. Then, the manuscript describes how economic evaluations in implementation science may differ from those in medicine and health intervention studies, especially in terms of determining the perspectives and outcomes of interest. Finally, referencing a scale-up trial of an evidence-based behavioral health intervention, concrete case examples of how cost data can be collected and used in economic evaluations targeting implementation, rather than clinical outcomes, are described. CONCLUSIONS: By gaining a greater understanding of the costs and economic impact associated with different implementation approaches, organizational decision-makers will have better transparency for future replication and scale-up. The use of economic evaluations can help to advance this understanding and provide researchers, purveyors or third-party intermediaries, and organizational decision-makers with essential information to facilitate implementation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s43058-022-00295-1. |
format | Online Article Text |
id | pubmed-9004101 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-90041012022-04-13 Using economic evaluations in implementation science to increase transparency in costs and outcomes for organizational decision-makers Saldana, Lisa Ritzwoller, Debra P. Campbell, Mark Block, Eryn Piper Implement Sci Commun Debate BACKGROUND: Economic evaluations frequently are utilized to compare the value of different interventions in medicine and health in concrete terms. Implementation science also would benefit from the incorporation of economic evaluations, but such studies are rare in the literature. The National Cancer Institute has supported a special collection of articles focusing on economic evaluations in implementation science. Even when interventions are supported by substantial evidence, they are implemented infrequently in the field. Implementation costs are important determinants for whether organizational decision-makers choose to adopt an intervention and whether the implementation process is successful. Economic evaluations, such as cost-effectiveness analyses, can help organizational decision-makers choose between implementation approaches for evidence-based interventions by accounting for costs and succinctly presenting cost/benefit tradeoffs. MAIN TEXT: This manuscript presents a discussion of important considerations for incorporating economic evaluations into implementation science. First, the distinction between intervention and implementation costs is presented, along with an explanation of why the comprehensive representation of implementation costs is elusive. Then, the manuscript describes how economic evaluations in implementation science may differ from those in medicine and health intervention studies, especially in terms of determining the perspectives and outcomes of interest. Finally, referencing a scale-up trial of an evidence-based behavioral health intervention, concrete case examples of how cost data can be collected and used in economic evaluations targeting implementation, rather than clinical outcomes, are described. CONCLUSIONS: By gaining a greater understanding of the costs and economic impact associated with different implementation approaches, organizational decision-makers will have better transparency for future replication and scale-up. The use of economic evaluations can help to advance this understanding and provide researchers, purveyors or third-party intermediaries, and organizational decision-makers with essential information to facilitate implementation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s43058-022-00295-1. BioMed Central 2022-04-11 /pmc/articles/PMC9004101/ /pubmed/35410434 http://dx.doi.org/10.1186/s43058-022-00295-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Debate Saldana, Lisa Ritzwoller, Debra P. Campbell, Mark Block, Eryn Piper Using economic evaluations in implementation science to increase transparency in costs and outcomes for organizational decision-makers |
title | Using economic evaluations in implementation science to increase transparency in costs and outcomes for organizational decision-makers |
title_full | Using economic evaluations in implementation science to increase transparency in costs and outcomes for organizational decision-makers |
title_fullStr | Using economic evaluations in implementation science to increase transparency in costs and outcomes for organizational decision-makers |
title_full_unstemmed | Using economic evaluations in implementation science to increase transparency in costs and outcomes for organizational decision-makers |
title_short | Using economic evaluations in implementation science to increase transparency in costs and outcomes for organizational decision-makers |
title_sort | using economic evaluations in implementation science to increase transparency in costs and outcomes for organizational decision-makers |
topic | Debate |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004101/ https://www.ncbi.nlm.nih.gov/pubmed/35410434 http://dx.doi.org/10.1186/s43058-022-00295-1 |
work_keys_str_mv | AT saldanalisa usingeconomicevaluationsinimplementationsciencetoincreasetransparencyincostsandoutcomesfororganizationaldecisionmakers AT ritzwollerdebrap usingeconomicevaluationsinimplementationsciencetoincreasetransparencyincostsandoutcomesfororganizationaldecisionmakers AT campbellmark usingeconomicevaluationsinimplementationsciencetoincreasetransparencyincostsandoutcomesfororganizationaldecisionmakers AT blockerynpiper usingeconomicevaluationsinimplementationsciencetoincreasetransparencyincostsandoutcomesfororganizationaldecisionmakers |